🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPharmacology & MechanismsGIP receptor pharmacology — January 2024 Page 3

GIP receptor pharmacology — January 2024

lisa_labSD Tue, Jan 23, 2024 at 8:49 PM 11 replies 2,054 viewsPage 3 of 3
JakeBK_lifts
Member
523
2,345
Jul 2024
Brooklyn, NY
Jan 24, 2024 at 1:04 AM#11

hank_denver — wow. This community is amazing.

28 20TrialTracker_MD, JennaRN, LabKate and 25 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Jan 24, 2024 at 1:21 AM#12

Slightly tangential to GIP receptor pharmacology but lisa_labSD reminded me — what is the latest on the oral formulations?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

Last edited: Jan 24, 2024 at 3:21 AM
11 19TomTeleRx, DoseLogDan, SleepFixSam and 8 others
Reply Quote Save Share Report
ingrid_STO
Member
345
1,456
Jul 2024
Stockholm, SE
Jan 24, 2024 at 1:38 AM#13

Thanks for sharing this, lisa_labSD. A few questions about your GIP receptor experience:

  1. What dose did you start at?
  2. How long before you noticed side effects improving?
  3. Did your provider have any specific recommendations about GIP receptor?

I am in a similar boat and trying to learn from others' experiences before my next appointment.

11 9MikeFit_NJ, InsuranceTom, WendyG_ATL and 8 others
Reply Quote Save Share Report
lisa_labSD
Member
278
1,234
Oct 2024
San Diego, CA
Jan 24, 2024 at 1:55 AM#14

OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on GIP receptor pharmacology.

To answer mike_mod: yes, I am on compounded sema from a 503B pharmacy.

Quick update: things are still going well. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏

19 1lori_vegas, Dr.PulmRoch, maya_sedona and 16 others
Reply Quote Save Share Report
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
Jan 24, 2024 at 2:12 AM#15

Relevant to GIP receptor pharmacology — here is my latest bloodwork comparison:

Key improvements: A1C 8.4% → 5.5%, triglycerides 205 → 105 mg/dL, hsCRP 8.0 → 1.1 mg/L. All on tirzepatide for 9 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

38 12DeniseRN_TPA, SandraNC_45, Dr.EndoIndy and 35 others
Reply Quote Save Share Report

Similar Threads

GLP-1R desensitization — β-arrestin-mediated internalization18 replies
Biased agonism at GLP-1R — Gs vs β-arrestin signaling balance13 replies
Semaglutide albumin binding and the C-18 fatty acid linker17 replies
GIP receptor pharmacology — why GIP agonism enhances GLP-113 replies
Glucagon receptor signaling — hepatic glycogenolysis and lipolysis16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register